| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Neoplasms | 13 | 2021 | 560 | 3.130 |
Why?
|
| Gene Editing | 9 | 2024 | 229 | 2.300 |
Why?
|
| CRISPR-Cas Systems | 10 | 2024 | 362 | 2.250 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 8 | 2021 | 346 | 1.810 |
Why?
|
| Teratoma | 4 | 2021 | 248 | 1.470 |
Why?
|
| Embryonic Germ Cells | 3 | 2021 | 9 | 1.340 |
Why?
|
| Embryo, Mammalian | 5 | 2024 | 746 | 1.230 |
Why?
|
| Cell Differentiation | 7 | 2025 | 4105 | 1.010 |
Why?
|
| Time-Lapse Imaging | 1 | 2024 | 22 | 0.930 |
Why?
|
| Mice, Knockout | 19 | 2025 | 5692 | 0.920 |
Why?
|
| Embryonal Carcinoma Stem Cells | 3 | 2021 | 13 | 0.890 |
Why?
|
| Mice | 50 | 2025 | 35477 | 0.860 |
Why?
|
| Embryonic Development | 2 | 2024 | 313 | 0.830 |
Why?
|
| Sex Differentiation | 1 | 2021 | 41 | 0.750 |
Why?
|
| Machine Learning | 1 | 2024 | 365 | 0.730 |
Why?
|
| Animals | 53 | 2025 | 61554 | 0.620 |
Why?
|
| Intestinal Polyposis | 2 | 2015 | 29 | 0.600 |
Why?
|
| Germ Cells | 4 | 2023 | 329 | 0.600 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 124 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 7054 | 0.600 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 164 | 0.570 |
Why?
|
| Osteoblasts | 3 | 2025 | 398 | 0.550 |
Why?
|
| Cyclin D1 | 2 | 2016 | 591 | 0.530 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 46 | 0.530 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2024 | 5775 | 0.520 |
Why?
|
| Genes, Lethal | 2 | 2022 | 131 | 0.520 |
Why?
|
| Testis | 2 | 2017 | 620 | 0.510 |
Why?
|
| Genetic Association Studies | 5 | 2021 | 1098 | 0.460 |
Why?
|
| Ovary | 1 | 2017 | 687 | 0.430 |
Why?
|
| Interleukins | 1 | 2015 | 341 | 0.410 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 100 | 0.380 |
Why?
|
| Genome | 4 | 2023 | 689 | 0.350 |
Why?
|
| Mice, Transgenic | 9 | 2024 | 4202 | 0.330 |
Why?
|
| Osteoporosis | 2 | 2021 | 232 | 0.320 |
Why?
|
| Alleles | 7 | 2024 | 2597 | 0.320 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 90 | 0.310 |
Why?
|
| Integrases | 3 | 2023 | 254 | 0.310 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 83 | 0.310 |
Why?
|
| Intellectual Disability | 3 | 2021 | 1064 | 0.310 |
Why?
|
| Mice, 129 Strain | 3 | 2018 | 160 | 0.300 |
Why?
|
| Transgenes | 2 | 2006 | 568 | 0.280 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 1437 | 0.280 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 7320 | 0.280 |
Why?
|
| Chromosomes, Artificial | 1 | 2006 | 1 | 0.280 |
Why?
|
| Genes, Essential | 2 | 2024 | 56 | 0.280 |
Why?
|
| Phenotype | 10 | 2024 | 6503 | 0.270 |
Why?
|
| Stem Cells | 4 | 2024 | 1213 | 0.260 |
Why?
|
| Gene Deletion | 5 | 2021 | 1471 | 0.260 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2024 | 1462 | 0.250 |
Why?
|
| Cell Proliferation | 5 | 2022 | 7232 | 0.240 |
Why?
|
| Forkhead Transcription Factors | 2 | 2021 | 761 | 0.240 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 59 | 0.240 |
Why?
|
| Oocytes | 2 | 2024 | 413 | 0.240 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2004 | 45 | 0.240 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 18 | 0.240 |
Why?
|
| Zygote | 1 | 2024 | 41 | 0.230 |
Why?
|
| RANK Ligand | 1 | 2025 | 120 | 0.230 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2004 | 127 | 0.230 |
Why?
|
| Osteoclasts | 2 | 2025 | 160 | 0.230 |
Why?
|
| Mutation | 12 | 2024 | 15904 | 0.230 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 1016 | 0.220 |
Why?
|
| Male | 24 | 2024 | 128484 | 0.220 |
Why?
|
| Mice, Inbred Strains | 3 | 2023 | 556 | 0.220 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2023 | 59 | 0.210 |
Why?
|
| Ciliopathies | 1 | 2022 | 12 | 0.210 |
Why?
|
| SOX9 Transcription Factor | 1 | 2024 | 177 | 0.210 |
Why?
|
| Gene Targeting | 1 | 2004 | 312 | 0.210 |
Why?
|
| Anophthalmos | 1 | 2023 | 25 | 0.210 |
Why?
|
| Coloboma | 1 | 2023 | 45 | 0.210 |
Why?
|
| Capsid | 1 | 2023 | 178 | 0.210 |
Why?
|
| Microphthalmos | 1 | 2023 | 65 | 0.210 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 396 | 0.210 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2021 | 90 | 0.210 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 337 | 0.200 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 16 | 0.200 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2024 | 149 | 0.200 |
Why?
|
| Eye Abnormalities | 1 | 2023 | 115 | 0.200 |
Why?
|
| DNA Helicases | 1 | 2025 | 460 | 0.200 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 332 | 0.200 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 251 | 0.200 |
Why?
|
| Epithelial Cells | 2 | 2022 | 1877 | 0.190 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 17 | 0.190 |
Why?
|
| Pyroptosis | 1 | 2022 | 39 | 0.190 |
Why?
|
| Coatomer Protein | 1 | 2021 | 33 | 0.190 |
Why?
|
| Semaphorins | 1 | 2021 | 37 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2025 | 1495 | 0.190 |
Why?
|
| Neoplasm Proteins | 4 | 2024 | 3345 | 0.190 |
Why?
|
| Exons | 3 | 2023 | 1390 | 0.190 |
Why?
|
| Aniridia | 1 | 2021 | 17 | 0.190 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 1197 | 0.190 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 39 | 0.190 |
Why?
|
| Cells | 1 | 2021 | 38 | 0.190 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4796 | 0.180 |
Why?
|
| Endometriosis | 1 | 2024 | 232 | 0.180 |
Why?
|
| Female | 22 | 2024 | 149120 | 0.180 |
Why?
|
| Bone and Bones | 2 | 2021 | 605 | 0.180 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 196 | 0.180 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 72 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 617 | 0.180 |
Why?
|
| Genotype | 5 | 2021 | 4249 | 0.180 |
Why?
|
| Spermatogonia | 1 | 2021 | 101 | 0.180 |
Why?
|
| Synapses | 1 | 2024 | 541 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 9044 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2024 | 2923 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 2 | 2025 | 1582 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 883 | 0.170 |
Why?
|
| Introns | 1 | 2021 | 461 | 0.170 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 101 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 3707 | 0.170 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 18 | 0.160 |
Why?
|
| Population Health | 1 | 2020 | 54 | 0.160 |
Why?
|
| Flow Cytometry | 2 | 2018 | 3042 | 0.160 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 75 | 0.160 |
Why?
|
| Sex Determination Processes | 1 | 2018 | 15 | 0.150 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 77 | 0.150 |
Why?
|
| Disease | 1 | 2020 | 165 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 228 | 0.150 |
Why?
|
| Bone Density | 1 | 2020 | 467 | 0.150 |
Why?
|
| Genomics | 2 | 2020 | 2832 | 0.150 |
Why?
|
| Gene Dosage | 3 | 2017 | 822 | 0.150 |
Why?
|
| Pregnancy | 3 | 2024 | 8131 | 0.140 |
Why?
|
| Electrocardiography | 1 | 2023 | 1147 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2021 | 12044 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 356 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 818 | 0.140 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 88 | 0.140 |
Why?
|
| Complement C5a | 1 | 2016 | 32 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 696 | 0.140 |
Why?
|
| Lung | 3 | 2024 | 3288 | 0.140 |
Why?
|
| Leydig Cells | 1 | 2016 | 34 | 0.130 |
Why?
|
| Aging | 1 | 2024 | 1531 | 0.130 |
Why?
|
| Sequence Deletion | 2 | 2017 | 908 | 0.130 |
Why?
|
| Nuclear Proteins | 2 | 2025 | 3435 | 0.130 |
Why?
|
| Transcription Factors | 3 | 2023 | 5416 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 229 | 0.130 |
Why?
|
| Gene Expression | 3 | 2017 | 3606 | 0.130 |
Why?
|
| Interleukin-33 | 1 | 2015 | 19 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 573 | 0.130 |
Why?
|
| Sertoli Cells | 1 | 2016 | 121 | 0.130 |
Why?
|
| Meiosis | 1 | 2016 | 175 | 0.120 |
Why?
|
| Mutagenesis | 3 | 2023 | 511 | 0.120 |
Why?
|
| Wound Healing | 2 | 2022 | 770 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 1580 | 0.120 |
Why?
|
| Gene Knockout Techniques | 3 | 2022 | 267 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 489 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 244 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2015 | 93 | 0.120 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 205 | 0.120 |
Why?
|
| Transcriptome | 3 | 2022 | 1960 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 7645 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 4104 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2015 | 245 | 0.110 |
Why?
|
| Osteogenesis | 2 | 2024 | 272 | 0.110 |
Why?
|
| Proteins | 3 | 2023 | 2029 | 0.110 |
Why?
|
| Homozygote | 2 | 2022 | 772 | 0.110 |
Why?
|
| Mitosis | 1 | 2016 | 679 | 0.110 |
Why?
|
| Mast Cells | 1 | 2015 | 224 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 658 | 0.100 |
Why?
|
| Humans | 26 | 2024 | 271093 | 0.100 |
Why?
|
| Software | 1 | 2020 | 1358 | 0.100 |
Why?
|
| Genome, Human | 1 | 2021 | 1896 | 0.100 |
Why?
|
| Colonic Polyps | 1 | 2015 | 228 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2012 | 84 | 0.100 |
Why?
|
| Histological Techniques | 1 | 2012 | 63 | 0.100 |
Why?
|
| Capsid Proteins | 2 | 2023 | 219 | 0.100 |
Why?
|
| Nanog Homeobox Protein | 1 | 2012 | 63 | 0.100 |
Why?
|
| Inheritance Patterns | 2 | 2012 | 136 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2019 | 1555 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 2105 | 0.100 |
Why?
|
| Base Sequence | 4 | 2022 | 5417 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 617 | 0.090 |
Why?
|
| DNA Damage | 1 | 2019 | 1990 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1023 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 790 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2019 | 2163 | 0.090 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 23 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2012 | 574 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 4642 | 0.090 |
Why?
|
| Obesity | 2 | 2016 | 2900 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 2478 | 0.080 |
Why?
|
| Animals, Congenic | 1 | 2008 | 9 | 0.080 |
Why?
|
| Solubility | 1 | 2008 | 247 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 1586 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 251 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2023 | 1847 | 0.070 |
Why?
|
| RNA, Messenger | 5 | 2013 | 6343 | 0.070 |
Why?
|
| Cytokines | 1 | 2016 | 2805 | 0.070 |
Why?
|
| Zebrafish | 2 | 2021 | 457 | 0.070 |
Why?
|
| Triglycerides | 1 | 2010 | 610 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2010 | 436 | 0.070 |
Why?
|
| Epistasis, Genetic | 1 | 2007 | 120 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 51 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 1124 | 0.070 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 623 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 380 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2008 | 603 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2008 | 843 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 314 | 0.060 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 203 | 0.060 |
Why?
|
| Biometry | 1 | 2008 | 251 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 216 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 16 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 29 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2007 | 340 | 0.060 |
Why?
|
| Bone Development | 1 | 2025 | 87 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2021 | 5662 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2010 | 719 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2004 | 88 | 0.060 |
Why?
|
| Genetic Therapy | 2 | 2022 | 1715 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2021 | 1647 | 0.060 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2025 | 122 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 825 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 183 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 4994 | 0.050 |
Why?
|
| X Chromosome | 1 | 2004 | 400 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2021 | 17095 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2024 | 290 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 6655 | 0.050 |
Why?
|
| Age Factors | 1 | 2012 | 5458 | 0.050 |
Why?
|
| Dependovirus | 1 | 2023 | 142 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 154 | 0.050 |
Why?
|
| Cilia | 1 | 2022 | 90 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 469 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 372 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2024 | 526 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2022 | 157 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2453 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2004 | 489 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 6191 | 0.050 |
Why?
|
| Bivalvia | 1 | 2001 | 16 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 367 | 0.050 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 46 | 0.050 |
Why?
|
| Eye | 1 | 2023 | 284 | 0.050 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 29 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 130 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 163 | 0.050 |
Why?
|
| Progesterone | 1 | 2024 | 711 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2020 | 80 | 0.050 |
Why?
|
| Facies | 1 | 2021 | 159 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 452 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 151 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 241 | 0.050 |
Why?
|
| Apoptosis | 1 | 2015 | 7755 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2021 | 186 | 0.050 |
Why?
|
| Endometrium | 1 | 2024 | 457 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 3412 | 0.040 |
Why?
|
| Estrogens | 1 | 2024 | 807 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 151 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 301 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 329 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 135 | 0.040 |
Why?
|
| Brain | 2 | 2024 | 4205 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 186 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 1456 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 326 | 0.040 |
Why?
|
| Binding Sites | 2 | 2017 | 2249 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2022 | 1023 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 3204 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 367 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 271 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 107 | 0.040 |
Why?
|
| Genes | 1 | 2020 | 605 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 925 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 1072 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2022 | 881 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 269 | 0.040 |
Why?
|
| Methotrexate | 1 | 2022 | 1025 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 206 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 426 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 1610 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 1459 | 0.040 |
Why?
|
| Amino Acids | 1 | 2020 | 746 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2022 | 1492 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 1127 | 0.030 |
Why?
|
| Cell Line | 1 | 2004 | 5326 | 0.030 |
Why?
|
| Internet | 1 | 2021 | 690 | 0.030 |
Why?
|
| Complement Activation | 1 | 2016 | 87 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 2016 | 208 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2022 | 2414 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 2189 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 2261 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 2357 | 0.030 |
Why?
|
| DNA Primers | 2 | 2007 | 1492 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 573 | 0.030 |
Why?
|
| Cell Movement | 1 | 2022 | 2468 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 2112 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2022 | 4906 | 0.030 |
Why?
|
| Child | 3 | 2021 | 30596 | 0.030 |
Why?
|
| Neurons | 1 | 2024 | 2446 | 0.030 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2012 | 14 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 784 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 3472 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 2041 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 2346 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2022 | 6240 | 0.020 |
Why?
|
| Lewis X Antigen | 1 | 2011 | 38 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2019 | 1210 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 997 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2011 | 105 | 0.020 |
Why?
|
| Epigenomics | 1 | 2012 | 272 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 4392 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 3473 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 1058 | 0.020 |
Why?
|
| RNA Splicing Factors | 1 | 2010 | 151 | 0.020 |
Why?
|
| Lipolysis | 1 | 2010 | 101 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 1310 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 94 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 5143 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 1247 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2010 | 224 | 0.020 |
Why?
|
| Muscles | 1 | 2010 | 443 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 630 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 3657 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8709 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 610 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 32784 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 2186 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 690 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2007 | 52 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 327 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 1129 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 7900 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1576 | 0.010 |
Why?
|
| Glucose | 1 | 2010 | 1209 | 0.010 |
Why?
|
| United States | 1 | 2021 | 15891 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 1289 | 0.010 |
Why?
|
| Hemocytes | 1 | 2001 | 10 | 0.010 |
Why?
|
| Tumor Protein p73 | 1 | 2001 | 114 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2001 | 87 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 5317 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 22293 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 3063 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 1075 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 860 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 866 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 4542 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 1900 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 82174 | 0.010 |
Why?
|
| Leukemia | 1 | 2001 | 1719 | 0.010 |
Why?
|